|
US2642514A
(en)
|
1946-08-10 |
1953-06-16 |
American Cyanamid Co |
Ion exchange process with magnetic ion exchange resins
|
|
GB1239978A
(en)
|
1968-07-15 |
1971-07-21 |
Permutt Company Ltd |
Ion-exchange processes
|
|
US5516931A
(en)
|
1982-02-01 |
1996-05-14 |
Northeastern University |
Release tag compounds producing ketone signal groups
|
|
US5650270A
(en)
|
1982-02-01 |
1997-07-22 |
Northeastern University |
Molecular analytical release tags and their use in chemical analysis
|
|
US4650750A
(en)
|
1982-02-01 |
1987-03-17 |
Giese Roger W |
Method of chemical analysis employing molecular release tag compounds
|
|
US4709016A
(en)
|
1982-02-01 |
1987-11-24 |
Northeastern University |
Molecular analytical release tags and their use in chemical analysis
|
|
US5595756A
(en)
|
1993-12-22 |
1997-01-21 |
Inex Pharmaceuticals Corporation |
Liposomal compositions for enhanced retention of bioactive agents
|
|
US20020164788A1
(en)
|
1994-12-02 |
2002-11-07 |
The Wellcome Foundation Limited |
Humanized antibodies to CD38
|
|
EP0859841B1
(en)
|
1995-08-18 |
2002-06-19 |
MorphoSys AG |
Protein/(poly)peptide libraries
|
|
EP0941120A4
(en)
|
1996-11-05 |
2004-08-18 |
Bristol Myers Squibb Co |
BRANCHED PEPTIDLINKERS
|
|
US6326144B1
(en)
|
1998-09-18 |
2001-12-04 |
Massachusetts Institute Of Technology |
Biological applications of quantum dots
|
|
WO2000029617A2
(en)
|
1998-09-24 |
2000-05-25 |
Advanced Research And Technology Institute, Inc. |
Water-soluble luminescent quantum dots and bioconjugates thereof
|
|
US6927203B1
(en)
|
1999-08-17 |
2005-08-09 |
Purdue Research Foundation |
Treatment of metastatic disease
|
|
AU2003217606C1
(en)
|
2002-02-21 |
2008-07-17 |
Institute Of Virology |
Soluble Form of Carbonic Anhydrase IX (s-CA IX), Assays to Detect s-CA IX, CA IXs Coexpression with HER-2/neu/c-erbB-2 and CA IX-Specific Monoclonal Antibodies to Non-Immunodominant Epitopes
|
|
KR20050091716A
(ko)
|
2002-12-12 |
2005-09-15 |
텔 아비브 유니버시티 퓨쳐 테크놀로지 디벨롭먼트 엘.피. |
글리코겐 신타제 키나제-3 억제제
|
|
EP1452868A2
(en)
|
2003-02-27 |
2004-09-01 |
Pepscan Systems B.V. |
Method for selecting a candidate drug compound
|
|
EP2915820A1
(en)
|
2004-02-06 |
2015-09-09 |
MorphoSys AG |
Anti-CD38 human antibodies and uses therefor
|
|
CA2505655C
(en)
|
2004-04-28 |
2013-07-09 |
Warren Chan |
Stable, water-soluble quantum dot, method of preparation and conjugates thereof
|
|
ES2428869T3
(es)
|
2005-01-24 |
2013-11-12 |
Pepscan Systems B.V. |
Compuestos de unión, compuestos inmunógenos y peptidomiméticos
|
|
US7989590B2
(en)
|
2005-03-22 |
2011-08-02 |
Rohto Pharmaceutical Co., Ltd |
Peptides that increase collagen or hyaluronic acid production
|
|
KR20080080482A
(ko)
|
2005-09-07 |
2008-09-04 |
메디뮨 엘엘씨 |
독소가 컨쥬게이트된 ｅｐｈ 수용체 항체
|
|
WO2007093836A1
(en)
|
2006-02-13 |
2007-08-23 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from a xp gene and uses thereof
|
|
US7666392B2
(en)
|
2006-09-15 |
2010-02-23 |
Siemens Medical Solutions Usa, Inc. |
Click chemistry-derived cyclopeptide derivatives as imaging agents for integrins
|
|
CN101232326B
(zh)
|
2007-01-22 |
2012-01-11 |
中兴通讯股份有限公司 |
用于无源光网络系统的动态带宽分配装置及其实现方法
|
|
US20090110662A1
(en)
|
2007-04-30 |
2009-04-30 |
Intezyne Technologies, Inc. |
Modification of biological targeting groups for the treatment of cancer
|
|
CN101918844A
(zh)
|
2007-06-18 |
2010-12-15 |
米迪缪尼有限公司 |
表达epha2和erbb2的细胞的协同治疗
|
|
WO2009097397A2
(en)
|
2008-01-30 |
2009-08-06 |
Dyax Corp. |
Metalloproteinase binding proteins
|
|
CN101497878B
(zh)
|
2008-01-30 |
2012-11-07 |
房学迅 |
特异性高效亲和膜ⅰ型基质金属蛋白酶(mt1-mmp)的多肽、蛋白及其应用
|
|
JP6074574B2
(ja)
|
2008-02-05 |
2017-02-08 |
バイシクル セラピューティクス リミテッド |
方法及び組成物
|
|
PT2257309T
(pt)
|
2008-02-27 |
2020-01-22 |
Yeda Res And Development Company Ltd |
Conjugados rgd-(bacterio)clorofila para utilização no diagnóstico de tumores compreendendo domínios necróticos
|
|
US8293714B2
(en)
|
2008-05-05 |
2012-10-23 |
Covx Technology Ireland, Ltd. |
Anti-angiogenic compounds
|
|
FR2932189A1
(fr)
|
2008-06-10 |
2009-12-11 |
Commissariat Energie Atomique |
Biopuces pour la detection de l'activite enzymatique d'une enzyme protease
|
|
GB0913775D0
(en)
|
2009-08-06 |
2009-09-16 |
Medical Res Council |
Multispecific peptides
|
|
CA2769444A1
(en)
|
2009-05-19 |
2010-11-25 |
Aic Blab Company |
Composite current collector and methods therefor
|
|
GB0914110D0
(en)
|
2009-08-12 |
2009-09-16 |
Medical Res Council |
Peptide libraries
|
|
AU2010321738B2
(en)
|
2009-11-23 |
2016-07-14 |
Palatin Technologies, Inc. |
Melanocortin-1 receptor-specific cyclic peptides
|
|
US9073974B2
(en)
|
2009-12-21 |
2015-07-07 |
The Regents Of The University Of California |
RGD-containing cyclic peptides
|
|
EP2343081A1
(en)
|
2009-12-31 |
2011-07-13 |
Rijksuniversiteit Groningen |
Interferon analogs
|
|
WO2012057624A1
(en)
|
2010-10-25 |
2012-05-03 |
Pepscan Systems B.V. |
Novel bicyclic peptide mimetics
|
|
US20130072598A1
(en)
|
2011-03-18 |
2013-03-21 |
Board Of Regents Of The University Of Nebraska |
Thermoplastics from Distillers Dried Grains and Feathers
|
|
JP6254527B2
(ja)
|
2011-10-07 |
2017-12-27 |
バイサイクル・セラピューティクス・リミテッド |
構造化ポリペプチドの特異性のモジュレーション
|
|
GB201117428D0
(en)
|
2011-10-07 |
2011-11-23 |
Bicycle Therapeutics Ltd |
Structured polypeptides with sarcosine linkers
|
|
US9670521B2
(en)
|
2012-09-24 |
2017-06-06 |
Medimmune Limited |
Amino acid derivatives
|
|
US9587001B2
(en)
|
2012-10-19 |
2017-03-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
Conjugated knottin mini-proteins containing non-natural amino acids
|
|
CN111363047A
(zh)
|
2013-03-12 |
2020-07-03 |
分子模板公司 |
用于引起细胞内化的cd20结合免疫毒素及其使用方法
|
|
US20140274759A1
(en)
|
2013-03-15 |
2014-09-18 |
Bicycle Therapeutics Limited |
Modification of polypeptides
|
|
US10233249B2
(en)
|
2013-03-19 |
2019-03-19 |
Beijing Shenogen Pharma Group Ltd. |
Antibodies and methods for treating estrogen receptor-associated diseases
|
|
GB201306623D0
(en)
|
2013-04-11 |
2013-05-29 |
Bicycle Therapeutics Ltd |
Modulation of structured polypeptide specificity
|
|
ES2705068T3
(es)
|
2013-05-23 |
2019-03-21 |
Ohio State Innovation Foundation |
Síntesis química y cribado de bibliotecas de péptidos bicíclicos
|
|
KR20250051130A
(ko)
|
2013-09-25 |
2025-04-16 |
싸이톰스 테라퓨틱스, 인크. |
매트릭스 메탈로프로테이나제 기질 및 다른 절단성 모이어티 및 이의 사용 방법
|
|
WO2015063465A2
(en)
|
2013-10-28 |
2015-05-07 |
Bicycle Therapeutics Limited |
Novel polypeptides
|
|
DK3102576T3
(da)
|
2014-02-03 |
2019-07-22 |
Vitae Pharmaceuticals Llc |
Dihydropyrrolopyridininhibitorer af ror-gamma
|
|
AU2015255883A1
(en)
|
2014-05-08 |
2016-10-27 |
Novodiax, Inc. |
Direct immunohistochemistry assay
|
|
PT3149025T
(pt)
|
2014-05-21 |
2019-08-01 |
Entrada Therapeutics Inc |
Peptídeos penetrantes de células e métodos de fabrico e utilização dos mesmos
|
|
GB201416960D0
(en)
|
2014-09-25 |
2014-11-12 |
Antikor Biopharma Ltd |
Biological materials and uses thereof
|
|
US10654897B2
(en)
|
2014-09-30 |
2020-05-19 |
Polyphor Ag |
β-hairpin peptidomimetics
|
|
CA2963556C
(en)
|
2014-10-24 |
2023-03-14 |
Research Corporation Technologies, Inc. |
Small antibody-like polypeptides that bind to epha2 receptor
|
|
NZ731185A
(en)
|
2014-10-29 |
2024-03-22 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for mt1-mmp
|
|
CA2966005C
(en)
|
2014-10-31 |
2021-04-27 |
Abbvie Biotherapeutics Inc. |
Anti-cs1 antibodies and antibody drug conjugates
|
|
EP3903826B1
(en)
|
2014-12-04 |
2024-05-08 |
Celgene Corporation |
Biomolecule conjugates
|
|
IL237525A
(en)
|
2015-03-03 |
2017-05-29 |
Shalom Eli |
Method for labeling a prostate-specific membrane antigen with a radioactive isotope
|
|
CN107529836A
(zh)
|
2015-04-22 |
2018-01-02 |
三井化学株式会社 |
具有关节用支撑体部的衣物、及膝用支撑体
|
|
WO2016171242A1
(ja)
|
2015-04-24 |
2016-10-27 |
第一三共株式会社 |
Ｅｐｈａ２の検出
|
|
JP2018521960A
(ja)
|
2015-04-28 |
2018-08-09 |
エコール・ポリテクニーク・フェデラル・ドゥ・ローザンヌ（ウペエフエル）Ｅｃｏｌｅ Ｐｏｌｙｔｅｃｈｎｉｑｕｅ Ｆｅｄｅｒａｌｅ ｄｅ Ｌａｕｓａｎｎｅ （ＥＰＦＬ） |
酵素で活性化された第ＸＩＩ因子（ＦＸＩＩａ）の新規阻害剤
|
|
JP7366518B2
(ja)
|
2015-05-06 |
2023-10-23 |
ヤンセン バイオテツク，インコーポレーテツド |
前立腺特異的膜抗原結合フィブロネクチンｉｉｉ型ドメイン
|
|
EP3115066A1
(en)
|
2015-07-07 |
2017-01-11 |
Technische Universität München |
Novel psma-specific binding proteins
|
|
US9963495B2
(en)
|
2015-10-27 |
2018-05-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
Polypeptides targeting vascular endothelial growth factor receptor and prostate specific membrane antigen
|
|
EP3181146A1
(en)
|
2015-12-16 |
2017-06-21 |
Ruprecht-Karls-Universität Heidelberg |
Cyclic ntcp-targeting peptides and their uses as entry inhibitors
|
|
GB201600903D0
(en)
*
|
2016-01-18 |
2016-03-02 |
Bicycle Therapeutics Ltd |
Peptide derivaties
|
|
GB201600911D0
(en)
*
|
2016-01-18 |
2016-03-02 |
Bicycle Therapeutics Ltd |
Stabilized peptide derivatives
|
|
US10765625B2
(en)
|
2016-03-15 |
2020-09-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
Knottin-drug conjugates and methods of using the same
|
|
JP2019512477A
(ja)
|
2016-03-16 |
2019-05-16 |
メリマック ファーマシューティカルズ インコーポレーティッド |
エフリン受容体ａ２（ｅｐｈａ２）のナノリポソーム標的化及び関連する診断
|
|
KR102775461B1
(ko)
|
2016-04-01 |
2025-02-28 |
어비디티 바이오사이언시스 인크. |
핵산-폴리펩타이드 조성물 및 이의 용도
|
|
MX2018012803A
(es)
|
2016-04-20 |
2019-06-24 |
Hangzhou Dac Biotech Co Ltd |
Derivados de las toxinas de amanita y su conjugacion a una molecula de union celular.
|
|
BR112018071612A2
(pt)
|
2016-04-22 |
2019-02-19 |
Alligator Bioscience Ab |
polipeptídeos biespecíficos inovadores contra cd137
|
|
GB201607827D0
(en)
|
2016-05-04 |
2016-06-15 |
Bicycle Therapeutics Ltd |
Bicyclic peptide-toxin conjugates specific for MT1-MMP
|
|
KR20190014525A
(ko)
|
2016-05-27 |
2019-02-12 |
애브비 바이오테라퓨틱스 인크. |
면역 조절 단백질과 종양 항원을 결합하는 이중특이적 결합 단백질
|
|
WO2018096365A1
(en)
|
2016-11-27 |
2018-05-31 |
Bicyclerd Limited |
Methods for treating cancer
|
|
EP3559018A1
(en)
|
2016-12-23 |
2019-10-30 |
Bicyclerd Limited |
Peptide derivatives having novel linkage structures
|
|
MX2019007367A
(es)
|
2016-12-23 |
2020-01-27 |
Bicycletx Ltd |
Ligandos de peptido para enlace a mt1-mmp.
|
|
ES2985986T3
(es)
|
2017-01-06 |
2024-11-08 |
Bicyclerd Ltd |
Conjugado biciclo para tratar el cáncer
|
|
BR112019017628A2
(pt)
|
2017-02-24 |
2020-07-07 |
Macrogenics, Inc. |
molécula de ligação a cd137 x ta, composições farmacêuticas, uso da molécula de ligação a cd137 x ta, molécula de ligação a cd137, uso da molécula de ligação a cd137, molécula de ligação a her2/neu, uso da molécula de ligação a her2/neu, e uso de uma composição
|
|
GB201706477D0
(en)
|
2017-04-24 |
2017-06-07 |
Bicycle Therapeutics Ltd |
Modification of polypeptides
|
|
EP3615550A1
(en)
|
2017-04-27 |
2020-03-04 |
BicycleTx Limited |
Bicyclic peptide ligands and uses thereof
|
|
WO2018222987A1
(en)
|
2017-06-01 |
2018-12-06 |
Tarveda Therapeutics, Inc. |
Targeted constructs
|
|
WO2019002842A1
(en)
|
2017-06-26 |
2019-01-03 |
Bicyclerd Limited |
BICYCLIC PEPTIDE LIGANDS WITH DETECTABLE FRACTIONS AND USES THEREOF
|
|
JP7670481B2
(ja)
|
2017-08-04 |
2025-04-30 |
バイスクルテクス・リミテッド |
Ｃｄ１３７に対して特異的な二環式ペプチドリガンド
|
|
WO2019034868A1
(en)
|
2017-08-14 |
2019-02-21 |
Bicyclerd Limited |
CONJUGATES PEPTIDE BICYCLIC-LIGAND PPR-A AND USES THEREOF
|
|
WO2019034866A1
(en)
|
2017-08-14 |
2019-02-21 |
Bicyclerd Limited |
BICYCLIC PEPTIDE LIGANDS CONJUGATES AND USES THEREOF
|
|
WO2019084060A1
(en)
|
2017-10-24 |
2019-05-02 |
Silverback Therapeutics, Inc. |
CONJUGATES AND METHODS OF USE FOR THE SELECTIVE DELIVERY OF IMMUNOMODULATORY AGENTS
|
|
CA3247730A1
(en)
|
2017-11-07 |
2025-10-30 |
Regeneron Pharmaceuticals, Inc. |
Hydrophilic linkers for antibody drug conjugates
|
|
TWI825046B
(zh)
|
2017-12-19 |
2023-12-11 |
英商拜西可泰克斯有限公司 |
Epha2特用之雙環胜肽配位基
|
|
GB201721265D0
(en)
|
2017-12-19 |
2018-01-31 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for EphA2
|
|
US11572370B2
(en)
|
2018-01-08 |
2023-02-07 |
Biohaven Therapeutics Ltd. |
CD16A binding agents and uses thereof
|
|
CA3091775A1
(en)
|
2018-02-23 |
2019-08-29 |
Bicycletx Limited |
Multimeric bicyclic peptide ligands
|
|
CA3095582A1
(en)
|
2018-04-04 |
2019-10-10 |
Bicycletx Limited |
Heterotandem bicyclic peptide complexes
|
|
CN112384534A
(zh)
|
2018-05-21 |
2021-02-19 |
指南针制药有限责任公司 |
用于增强nk细胞对靶细胞的杀死的组合物和方法
|
|
GB201810327D0
(en)
|
2018-06-22 |
2018-08-08 |
Bicycletx Ltd |
Peptide ligands for binding to IL-17
|
|
US11180531B2
(en)
|
2018-06-22 |
2021-11-23 |
Bicycletx Limited |
Bicyclic peptide ligands specific for Nectin-4
|
|
GB201810325D0
(en)
|
2018-06-22 |
2018-08-08 |
Bicycletx Ltd |
Peptide ligands for binding to PSMA
|
|
GB201810316D0
(en)
|
2018-06-22 |
2018-08-08 |
Bicyclerd Ltd |
Peptide ligands for binding to EphA2
|
|
GB201810320D0
(en)
|
2018-06-22 |
2018-08-08 |
Bicycletx Ltd |
Peptide ligands for binding to CD38
|
|
GB201810329D0
(en)
|
2018-06-22 |
2018-08-08 |
Bicycletx Ltd |
Peptide ligands for binding to integrin avB3
|
|
WO2020084305A1
(en)
|
2018-10-23 |
2020-04-30 |
Bicycletx Limited |
Bicyclic peptide ligands and uses thereof
|
|
CA3116504A1
(en)
|
2018-10-30 |
2020-05-07 |
Bicyclerd Limited |
Bt1718 for use in treating cancer
|
|
GB201820325D0
(en)
|
2018-12-13 |
2019-01-30 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for psma
|
|
GB201820288D0
(en)
|
2018-12-13 |
2019-01-30 |
Bicycle Tx Ltd |
Bicycle peptide ligaands specific for MT1-MMP
|
|
GB201820295D0
(en)
|
2018-12-13 |
2019-01-30 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for MT1-MMP
|
|
SG11202106081YA
(en)
|
2018-12-13 |
2021-07-29 |
Bicycletx Ltd |
Bicyclic peptide ligands specific for mt1-mmp
|
|
JP7728701B2
(ja)
|
2018-12-17 |
2025-08-25 |
レビトープ リミテッド |
双子型免疫細胞エンゲージャー
|
|
WO2020128527A1
(en)
|
2018-12-21 |
2020-06-25 |
Bicyclerd Limited |
Bicyclic peptide ligands specific for pd-l1
|
|
EP3897849A1
(en)
|
2018-12-21 |
2021-10-27 |
BicycleTx Limited |
Bicyclic peptide ligands specific for pd-l1
|
|
US10882987B2
(en)
|
2019-01-09 |
2021-01-05 |
Nova Chemicals (International) S.A. |
Ethylene interpolymer products having intermediate branching
|
|
GB201900527D0
(en)
|
2019-01-15 |
2019-03-06 |
Bicycletx Ltd |
Bicyclic peptide ligands specific for integrin avb3
|
|
GB201900526D0
(en)
|
2019-01-15 |
2019-03-06 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for caix
|
|
GB201900530D0
(en)
|
2019-01-15 |
2019-03-06 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for CD38
|
|
GB201900528D0
(en)
|
2019-01-15 |
2019-03-06 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for integrin AVB3
|
|
GB201900525D0
(en)
|
2019-01-15 |
2019-03-06 |
Bicycletx Ltd |
Bicyclic peptide ligands specific for caix
|
|
GB201900529D0
(en)
|
2019-01-15 |
2019-03-06 |
Bicycletx Ltd |
Bicyclic peptide ligands specific for CD38
|
|
WO2020165600A1
(en)
|
2019-02-14 |
2020-08-20 |
Bicycletx Limited |
Bicyclic peptide ligand sting conjugates and uses thereof
|
|
WO2020178574A1
(en)
|
2019-03-04 |
2020-09-10 |
Bicyclerd Limited |
Synthesis of bicycle toxin conjugates, and intermediates thereof
|
|
US20220184222A1
(en)
|
2019-04-02 |
2022-06-16 |
Bicycletx Limited |
Bicycle toxin conjugates and uses thereof
|
|
KR20220007098A
(ko)
|
2019-05-09 |
2022-01-18 |
바이사이클티엑스 리미티드 |
Ox40에 특이적인 이환식 펩티드 리간드
|
|
TWI869398B
(zh)
|
2019-05-10 |
2025-01-11 |
英商拜西克爾德有限公司 |
治療癌症之方法
|
|
TWI860386B
(zh)
|
2019-07-30 |
2024-11-01 |
英商拜西可泰克斯有限公司 |
異質雙環肽複合物
|
|
US20220275053A1
(en)
|
2019-08-13 |
2022-09-01 |
Bicycletx Limited |
Modified multimeric bicyclic peptide ligands
|
|
GB201912320D0
(en)
|
2019-08-28 |
2019-10-09 |
Bicycletx Ltd |
PBP Binding Bicyclic Peptide Ligands
|
|
SI4464721T1
(sl)
|
2019-10-03 |
2025-08-29 |
Bicycletx Limited |
Heterotandemski biciklični peptidni kompleksi
|
|
GB201914872D0
(en)
|
2019-10-15 |
2019-11-27 |
Bicycletx Ltd |
Bicyclic peptide ligand drug conjugates
|
|
EP4045075A1
(en)
|
2019-10-16 |
2022-08-24 |
Bicyclerd Limited |
Methods for treating cancer
|
|
CN114760988A
(zh)
|
2019-11-27 |
2022-07-15 |
拜斯科技术开发有限公司 |
对EphA2具有特异性的双环肽配体和其用途
|
|
IT202000001231A1
(it)
|
2020-01-22 |
2021-07-22 |
Celery S R L |
Nuovi ceppi di batteri lattici, composizione alimentare che li comprende, preparazione di tale composizione
|
|
GB202002706D0
(en)
|
2020-02-26 |
2020-04-08 |
Bicycletx Ltd |
Pbp3 binding bicyclic peptide ligands
|
|
GB202002705D0
(en)
|
2020-02-26 |
2020-04-08 |
Bicycletx Ltd |
Anti-infective bicyclic peptide conjugates
|
|
AU2021276616A1
(en)
|
2020-05-20 |
2023-01-05 |
Bicycletx Limited |
Bicyclic peptide ligands specific for Nectin-4 and uses thereof
|
|
EP4165414A1
(en)
|
2020-06-12 |
2023-04-19 |
BicycleTX Limited |
Treatment of diseases characterized by overexpression of erythropoietin-producing hepatocellular receptor a2 (epha2)
|
|
CN116348476A
(zh)
|
2020-08-03 |
2023-06-27 |
拜斯科技术开发有限公司 |
基于肽的接头
|
|
WO2022038158A1
(en)
|
2020-08-17 |
2022-02-24 |
Bicycletx Limited |
Bicycle conjugates specific for nectin-4 and uses thereof
|
|
CA3206529A1
(en)
|
2021-01-08 |
2022-07-14 |
Bicycletx Limited |
Heterotandem bicyclic peptide complexes
|
|
JP2024504068A
(ja)
|
2021-01-08 |
2024-01-30 |
バイスクルテクス・リミテッド |
抗感染性二環式ペプチドリガンド
|
|
AU2022206394A1
(en)
|
2021-01-08 |
2023-08-24 |
Bicycletx Limited |
Bicyclic peptide ligands specific for nk cells
|
|
US20250186539A2
(en)
|
2021-01-11 |
2025-06-12 |
Bicycletx Limited |
Methods for treating cancer
|
|
WO2023031623A2
(en)
|
2021-09-03 |
2023-03-09 |
Bicycletx Limited |
Synthesis of bicycle toxin conjugates, and intermediates thereof
|
|
CN118475345A
(zh)
|
2021-11-16 |
2024-08-09 |
拜斯科技术开发有限公司 |
治疗癌症的方法
|